Page 12 - பல்கலைக்கழகம் ஆஃப் ஓக்லஹோமா ஆரோக்கியம் அறிவியல் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பல்கலைக்கழகம் ஆஃப் ஓக்லஹோமா ஆரோக்கியம் அறிவியல் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பல்கலைக்கழகம் ஆஃப் ஓக்லஹோமா ஆரோக்கியம் அறிவியல் மையம் Today - Breaking & Trending Today

Medical Marijuana Is Not Regulated as Most Medicines Are


Medical Marijuana Is Not Regulated as Most Medicines Are
The industry lacks randomized controlled clinical trials that can clearly establish benefits and risks.
Credit.Gracia Lam
Dan Shapiro was the first person I knew to use medical marijuana. As a junior at Vassar College in 1987, he was being treated for Hodgkin’s lymphoma with potent chemotherapy that caused severe nausea and vomiting. When Dan’s mother learned that smoking marijuana could relieve the distressing side effect, to help her son, this otherwise law-abiding woman planted a garden full of the illegal weed in her Connecticut back yard.
Decades later, marijuana as medicine has become a national phenomenon, widely accepted by the public. Although the chemical-rich plant botanically known as Cannabis sativa remains a federally controlled substance, its therapeutic use is now legal in 36 states and the District of Columbia. ....

Tennessee Valley , United States , District Of Columbia , Los Angeles , Sanjog Pangarkar , Peterr Wilson , Kenneth Finn , Jeanr Hausheer , Allenc Bowling , Dan Shapiro , Vassar College , University Of Oklahoma Health Sciences Center , Oregon Health Authority , Drug Administration , Neurohealth Institute In Englewood , Greater Los Angeles Va Healthcare Service , Colorado Springs , United States Pharmacopoeia , Marijuana Tax Act , Mayo Clinic , Addiction Medicine , Neurohealth Institute , Oklahoma Health Sciences Center , Valley Healthcare System , Medical Marijuana , Marijuana Pot Weed ,

Caisson Biotech and Heparinex Announce Positive Exam Report of European Patent


AUSTIN, Texas /Massachusetts Newswire – National News/ Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.
The HEPtune platform, which utilizes heparosan, a naturally occurring polysaccharide, has been validated as a novel half-life extension and drug delivery alternative to commonly used polyethylene glycol (PEG). Unlike PEG, heparosan is naturally found in humans, is completely biodegradable, and will not trigger anaphylactic shock or anti-drug antibodies. The HEPtune platform has been applied to numerous drug classes including biologics, and small molecules via nanocarriers, including liposomes. ....

United States , Paul Deangelis , Emergent Technologies Inc , Caisson Biotech , European Patent Office , University Of Oklahoma Health Sciences Center , National News , Stanford University , University Of Oklahoma Professor Dr , Massachusetts Newswire , Presidential Professor , Oklahoma Health Sciences Center , Chief Scientist , Oklahoma Professor , Emergent Technologies , ஒன்றுபட்டது மாநிலங்களில் , வெளிப்படுகிறது தொழில்நுட்பங்கள் இன்க் , கெயிசன் பயோடெக் , ஐரோப்பிய காப்புரிமை அலுவலகம் , பல்கலைக்கழகம் ஆஃப் ஓக்லஹோமா ஆரோக்கியம் அறிவியல் மையம் , தேசிய செய்தி , ஸ்டான்போர்ட் பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் ஓக்லஹோமா ப்ரொஃபெஸர் டாக்டர் , ப்ரெஸிடெந்ஶியல் ப்ரொஃபெஸர் , ஓக்லஹோமா ஆரோக்கியம் அறிவியல் மையம் , தலைமை விஞ்ஞானி ,

Tower Theatre to host Free COVID-19 Testing Event on March 1